Analysis of direct medical care costs of peptic ulcer disease in a Korean tertiary medical center

References

• Lambert JR, Dunn KL, Eaves ER, Korman MG, Hansky J, Pinkard KJ. Pyloric CLO in the human stomach. Med J Aust 1985;143:174.
   PubMed Web of Science ®Google Scholar
• Kim N, Park YJ, Ahn KJ, Lee GH, Lim BC, Koh YH, The role of Helicobacter pylori and NSAID in patients with benign gastric ulcer. Korean J Med 1998;54:502–13.
   Google Scholar
• Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JB. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999;94:1834–40.
   PubMed Web of Science ®Google Scholar
• Kim NY, Oh HS, Jung MH, Wee SH, Choi JH, Lee KH. The effect of eradication of Helicobacter pylori upon the duodenal ulcer recurrence–a 24 month follow-up study. Korean J Intern Med 1994;9:72–9.
   PubMedGoogle Scholar
• Hawkey CJ. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 2000;119:521–35.
   PubMed Web of Science ®Google Scholar
• Aalykke C, Lauritsen K. Epidemiology of NSAID-related gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol 2001;15:705–22.
   PubMed Web of Science ®Google Scholar
• Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333–40.
   PubMed Web of Science ®Google Scholar
• Chung JI, Kim N, Kang KP, Nam TM, Lee JH, Choi CH, Seroprevalence of H. pylori in the health check-up population in 2007. Korean J Helicobacter Upper Gastrointest Res 2008;8:71–5.
   Google Scholar
• Kim JI, Kim SG, Kim N, Kim JG, Shin SJ, Kim SW, Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol 2009;21:787–93.
   PubMed Web of Science ®Google Scholar
• Yu KD, Kim N, Park YS, Hwang JH, Kim JW, Lee DH, Clinical characteristics of elderly Korean patients with peptic ulcer. Korean J Med 2006;71:501–10.
   Google Scholar
• Jang HJ, Choi MH, Shin WG, Kim KH, Chung YW, Kim KO, Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study. Dig Dis Sci 2008;53:1527–31.
   PubMed Web of Science ®Google Scholar
• Hung LC, Ching JY, Sung JJ, To KF, Hui AJ, Wong VW, Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology 2005;128:1845–50.
   PubMed Web of Science ®Google Scholar
• Wong GL, Wong VW, Chan Y, Ching JY, Au K, Hui AJ, High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology 2009;137:525–31.
   PubMed Web of Science ®Google Scholar
• Sonnenberg A, Everhart JE. Health impact of peptic ulcer in the United States. Am J Gastroenterol 1997;92:614–20.
   PubMed Web of Science ®Google Scholar
• Levin TR, Schmittdiel JA, Kunz K, Henning JM, Henke CJ, Colby CJ, Costs of acid-related disorders to a health maintenance organization. Am J Med 1997;103:520–8.
   PubMed Web of Science ®Google Scholar
• Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 2002;20:347–55.
   PubMed Web of Science ®Google Scholar
• Seo PJ, Kim N, Oh JC, Lee BH, Shin CM, Suh S, Comparison of direct medical care costs between erosive reflux disease and non-erosive reflux disease in Korean tertiary medical center. J Neurogastroenterol Motil 2010;16:291–8.
   PubMedGoogle Scholar
• Shin WG, Kim HU, Kim SG, Kim GH, Shim K, Kim JW, Work productivity and activity impairment in gastroesophageal reflux disease in Korean full-time employees: a multicenter study. Dig Liver Dis 2011; in press.
   PubMedGoogle Scholar
• Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997;24:2–17.
   PubMed Web of Science ®Google Scholar
• Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Komatsu Y, Kagaya H, Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol 2000;12:635–40.
   PubMed Web of Science ®Google Scholar
• Chan HL, Wu JC, Chan FK, Choi CL, Ching JY, Lee YT, Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointest Endosc 2001;53:438–42.
   PubMed Web of Science ®Google Scholar
• Ruszniewski P. Pharmaco-economic considerations in the long-term management of peptic ulcer disease. Aliment Pharmacol Ther 1993;7(Suppl 2):41–8.
   PubMed Web of Science ®Google Scholar
• Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500–11.
   PubMed Web of Science ®Google Scholar
• Jonsson B, Haglund U. Economic burden of NSAID-induced gastropathy in Sweden. Scand J Gastroenterol 2001;36:775–9.
   PubMed Web of Science ®Google Scholar
• Joish VN, Donaldson G, Stockdale W, Oderda GM, Crawley J, Sasane R, The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Curr Med Res Opin 2005;21:535–44.
   PubMed Web of Science ®Google Scholar
• Gillen D, Wirz AA, Neithercut WD, Ardill JE, McColl KE. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut 1999;44:468–75.
   PubMed Web of Science ®Google Scholar
• Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol 2002;97:2950–61.
   PubMed Web of Science ®Google Scholar